3-oxoglycyrrhetinic acid has been researched along with acetylglycyrrhetinic acid in 5 studies
| Studies (3-oxoglycyrrhetinic acid) | Trials (3-oxoglycyrrhetinic acid) | Recent Studies (post-2010) (3-oxoglycyrrhetinic acid) | Studies (acetylglycyrrhetinic acid) | Trials (acetylglycyrrhetinic acid) | Recent Studies (post-2010) (acetylglycyrrhetinic acid) |
|---|---|---|---|---|---|
| 10 | 0 | 6 | 10 | 0 | 4 |
| Protein | Taxonomy | 3-oxoglycyrrhetinic acid (IC50) | acetylglycyrrhetinic acid (IC50) |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 4.622 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 3.78 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | Homo sapiens (human) | 2.0327 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amer, H; Beseda, I; Classen-Houben, D; Czollner, L; Da Cunha, T; Del Ruiz-Ruiz, MC; Gaware, R; Jordis, U; Khunt, R; Kosma, P; Mereiter, K; Odermatt, A; Shah, PS; Stanetty, C | 1 |
| Classen-Houben, D; Cunha, TD; Czollner, L; Gaware, R; Jordis, U; Koller, I; Kosma, P; Odermatt, A; Shah, P; Stanetty, C | 1 |
| Classen-Houben, D; Czollner, L; Da Cunha, T; Gaware, R; Jordis, U; Khunt, R; Kosma, P; Kratschmar, DV; Odermatt, A; Stanetty, C | 1 |
| Chen, H; Chen, JJ; Geng, CA; Huang, XY; Luo, J; Ma, YB; Wang, LJ; Zhang, XM | 1 |
| Ge, GB; Hao, DC; Hou, J; Jin, Q; Li, YG; Wang, P; Yang, L; Zhou, K; Zou, LW | 1 |
5 other study(ies) available for 3-oxoglycyrrhetinic acid and acetylglycyrrhetinic acid
| Article | Year |
|---|---|
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Crystallography, X-Ray; Glycyrrhetinic Acid; Humans; Metabolic Diseases; Models, Molecular | 2010 |
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Hydroxamic Acids; Rats; Structure-Activity Relationship | 2010 |
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Azepines; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Hydroxamic Acids; Structure-Activity Relationship; Urea | 2011 |
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Topics: Antiviral Agents; DNA Replication; DNA, Viral; Glycyrrhetinic Acid; Hepatitis B virus; Structure-Activity Relationship; Virus Replication | 2012 |
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Topics: Carboxylesterase; Drug Design; Enzyme Inhibitors; Glycyrrhetinic Acid; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2016 |